{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T14:02:22Z","timestamp":1768053742990,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To explore the clinical characteristics and related factors of children with acute disseminated encephalomyelitis (ADEM) with positive anti-myelin oligodendrocyte glycoprotein (MOG) antibody.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study was conducted and enrolled pediatric ADEM patients who underwent serum MOG antibody detection from May 2017 to August 2020. The patients were divided into two groups: MOG- immunoglobulin G (IgG) positive (<jats:italic>n<\/jats:italic>\u2009=\u200935) and MOG-IgG negative (<jats:italic>n<\/jats:italic>\u2009=\u200950). We analyzed the clinical characteristics of MOG-IgG-positive ADEM pediatric patients and conducted a comparative analysis between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-five patients (21 males and 14 females) in the MOG-IgG-positive group with encephalopathy, multifocal neurological symptoms, and typical magnetic resonance imaging (MRI) abnormalities were enrolled. They usually had a favorable outcome, while some suffered from relapse. Compared to the MOG-IgG-negative group, MOG-IgG-positive ADEM patients had a longer disease duration (median: 10 vs. 6\u2009days), more meningeal involvement (31.4% vs. 8%) and frontal lobe involvement (82.8% vs. 68%), higher relapse rates (14.3% vs. 2%), lower serum tumor necrosis factor (1\u201312.4\u2009pg\/ml, median 1.7 vs. 1\u201334\u2009pg\/ml, median 2.2) and interferon-gamma (1\u20139.4\u2009pg\/ml, median 1.3 vs. 1\u201364\u2009pg\/ml, median 3) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05, respectively). Multivariate logistic regression analysis showed that the longer disease duration, meningeal involvement and frontal lobe involvement were the correlated factors of patients with ADEM with MOG antibody (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings provide clinical evidence that MOG-IgG positivity is associated with longer disease duration, meningeal involvement, and frontal lobe involvement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02963-0","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:02:58Z","timestamp":1667977378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics and associated factors of pediatric acute disseminated encephalomyelitis patients with MOG antibodies: a retrospective study in Hangzhou, China"],"prefix":"10.1186","volume":"22","author":[{"given":"Jue","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"issue":"2","key":"2963_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev. Neurol. 2019;15(2):89\u2013102.","journal-title":"Nat Rev. Neurol."},{"issue":"2","key":"2963_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1352458515587751","volume":"22","author":"C Fernandez-Carbonell","year":"2016","unstructured":"Fernandez-Carbonell C, Vargas-Lowy D, Musallam A, Healy B, McLaughlin K, Wucherpfennig KW, et al. Clinical\u2002and\u2002MRI\u2002phenotype\u2002of\u2002children\u2002with\u2002MOG\u2002antibodies. Mult Scler. 2016;22(2):174\u201384.","journal-title":"Mult Scler."},{"issue":"3","key":"2963_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","volume":"89","author":"Y Hacohen","year":"2017","unstructured":"Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, et al. Diagnostic\u2002algorithm\u2002for\u2002relapsing\u2002acquired\u2002demyelinating\u2002syndromes\u2002in\u2002children. Neurology. 2017;89(3):269\u201378.","journal-title":"Neurology."},{"issue":"6","key":"2963_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.4103\/0028-3886.193808","volume":"64","author":"PP Giri","year":"2016","unstructured":"Giri PP, Bhattyacharya S, Das D, Mukhopadhaya S. Acute disseminated encephalomyelitis: A clinical and neuroradiological profile of pediatric patients. Neurol India. 2016;64(6):1187\u201392.","journal-title":"Neurol India."},{"issue":"10","key":"2963_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","volume":"19","author":"LB Krupp","year":"2013","unstructured":"Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al. International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013;19(10):1261\u20137.","journal-title":"Mult Scler."},{"key":"2963_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejpn.2020.10.005","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Wendel EM, Lechner C, Bartels F, Finke C, Breu M, et al. E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:41\u201353.","journal-title":"Eur J Paediatr Neurol."},{"issue":"5","key":"2963_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-0039-1693152","volume":"50","author":"JD Santoro","year":"2019","unstructured":"Santoro JD, Chitnis T. Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody. Neuropediatrics. 2019;50(5):273\u20139.","journal-title":"Neuropediatrics."},{"issue":"9","key":"2963_CR8","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/dmcn.13703","volume":"60","author":"S Duignan","year":"2018","unstructured":"Duignan S, Wright S, Rossor T, Cazabon J, Gilmour K, Ciccarelli O, et al. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes. Dev Med Child Neurol. 2018;60(9):958\u201362.","journal-title":"Dev Med Child Neurol."},{"issue":"5","key":"2963_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","volume":"139","author":"R H\u00f6ftberger","year":"2020","unstructured":"H\u00f6ftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020;139(5):875\u201392.","journal-title":"Acta Neuropathol."},{"issue":"5","key":"2963_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13365-015-0353-z","volume":"21","author":"I Steiner","year":"2015","unstructured":"Steiner I, Kennedy PG. Acute disseminated encephalomyelitis: current knowledge and open questions. J Neurovirol. 2015;21(5):473\u20139.","journal-title":"J Neurovirol."},{"issue":"3","key":"2963_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/1352458518823486","volume":"26","author":"T Rossor","year":"2020","unstructured":"Rossor T, Benetou C, Wright S, Duignan S, Lascelles K, Robinson R, et al. Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis. Mult Scler. 2020;26(3):333\u201342.","journal-title":"Mult Scler."},{"key":"2963_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C, et al. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:2\u201313.","journal-title":"Eur J Paediatr Neurol."},{"key":"2963_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fneur.2019.00415","volume":"10","author":"X Zhong","year":"2019","unstructured":"Zhong X, Zhou Y, Chang Y, Wang J, Shu Y, Sun X, et al. Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients. Front Neurol. 2019;10:415.","journal-title":"Front Neurol."},{"issue":"11","key":"2963_CR14","first-page":"210","volume":"7","author":"RB Paolilo","year":"2020","unstructured":"Paolilo RB, Deiva K, Neuteboom R, Rost\u00e1sy K, Lim M. Acute Disseminated Encephalomyelitis: Current Perspectives. Children (Basel). 2020;7(11):210.","journal-title":"Children (Basel)."},{"key":"2963_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejpn.2020.10.007","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Breu M, Wendel EM, Wassmer E, Lim M, Neuteboom RF, et al. E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:32\u201340.","journal-title":"Eur J Paediatr Neurol."},{"issue":"9","key":"2963_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","volume":"13","author":"F Deisenhammer","year":"2006","unstructured":"Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, et al. Guidelines\u2002on\u2002routine\u2002cerebrospinal\u2002fluid\u2002analysis. Report from an EFNS task force. Eur J Neurol. 2006;13(9):913\u201322.","journal-title":"Eur J Neurol."},{"issue":"4","key":"2963_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2013.03.021","volume":"49","author":"I Erol","year":"2013","unstructured":"Erol I, Ozkale Y, Alkan O, Alehan F. Acute disseminated encephalomyelitis in children and adolescents: a single center experience. Pediatr Neurol. 2013;49(4):266\u201373.","journal-title":"Pediatr Neurol."},{"issue":"3","key":"2963_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","volume":"86","author":"M Baumann","year":"2015","unstructured":"Baumann M, Sahin K, Lechner C, Hennes EM, Schanda K, Mader S, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry. 2015;86(3):265\u201372.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"14","key":"2963_CR19","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1177\/1352458516631038","volume":"22","author":"M Baumann","year":"2016","unstructured":"Baumann M, Hennes EM, Schanda K, Karenfort M, Kornek B, Seidl R, et al. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): extending the spectrum of MOG antibody positive diseases. Mult Scler. 2016;22(14):1821\u20139.","journal-title":"Mult Scler."},{"issue":"10","key":"2963_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.autrev.2015.06.002","volume":"14","author":"S Esposito","year":"2015","unstructured":"Esposito S, Di Pietro GM, Madini B, Mastrolia MV, Rigante D. A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children. Autoimmun Rev. 2015;14(10):923\u20139.","journal-title":"Autoimmun Rev."},{"issue":"2","key":"2963_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.25291","volume":"84","author":"M Spadaro","year":"2018","unstructured":"Spadaro M, Winklmeier S, Beltr\u00e1n E, Macrini C, H\u00f6ftberger R, Schuh E, et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann Neurol. 2018;84(2):315\u201328.","journal-title":"Ann Neurol."},{"key":"2963_CR22","doi-asserted-by":"publisher","first-page":"947630","DOI":"10.3389\/fneur.2022.947630","volume":"13","author":"GS Manzano","year":"2022","unstructured":"Manzano GS, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Levy M, et al. Positive\u2002Predictive\u2002Value\u2002of\u2002MOG-IgG\u2002for Clinically Defined\u2002MOG-AD Within a Real-World Cohort. Front Neurol. 2022;13:947630.","journal-title":"Front Neurol."},{"key":"2963_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","volume":"78","author":"E Sechi","year":"2021","unstructured":"Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, et al. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol. 2021;78:741.","journal-title":"JAMA Neurol."},{"issue":"2","key":"2963_CR24","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, et al. International\u2002multicenter\u2002examination\u2002of\u2002MOG\u2002antibody\u2002assays. Neurol Neuroimmunol Neuroinflamm. 2020;7(2):e674.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"2963_CR25","doi-asserted-by":"crossref","first-page":"175628642094513","DOI":"10.1177\/1756286420945135","volume":"13","author":"H Hegen","year":"2020","unstructured":"Hegen H, Reindl M. Recent\u2002developments\u2002in\u2002MOG-IgG\u2002associated\u2002neurological\u2002disorders. Ther Adv Neurol Disord. 2020;13:1756286420945135.","journal-title":"Ther Adv Neurol Disord."},{"issue":"3","key":"2963_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40272-021-00441-7","volume":"23","author":"CX Wang","year":"2021","unstructured":"Wang CX. Assessment and Management of Acute Disseminated Encephalomyelitis (ADEM) in the Pediatric Patient. Paediatr Drugs. 2021;23(3):213\u201321.","journal-title":"Paediatr Drugs."},{"issue":"9","key":"2963_CR27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","volume":"89","author":"EM Hennes","year":"2017","unstructured":"Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, et al. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 2017;89(9):900\u20138.","journal-title":"Neurology."},{"issue":"11","key":"2963_CR28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS L\u00f3pez-Chiriboga","year":"2018","unstructured":"L\u00f3pez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, et al. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. JAMA Neurol. 2018;75(11):1355\u201363.","journal-title":"JAMA Neurol."},{"issue":"7","key":"2963_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1352458519845112","volume":"26","author":"CL de Mol","year":"2020","unstructured":"de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, et al. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020;26(7):806\u201314.","journal-title":"Mult Scler."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02963-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:03:06Z","timestamp":1667977386000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2963"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02963-0","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"7 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Children\u2019s Hospital of Zhejiang University School of Medicine, China (2019-IRB-115). All parents of pediatric patients provided informed consent for this study. This study was carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}